Documents
HPLC as a Complimentary Technique to Quantify Bevacizumab
In this application note, we provide a simple, rapid, and low-cost method for the quantification of Bevacizumab formulated in HSA-based nanoparticles using a Biozen 3 µm dSEC-2 HPLC Column.
HPLC as a Complimentary Technique to Quantify Bevacizumab
In this application note, we provide a simple, rapid, and low-cost method for the quantification of Bevacizumab formulated in HSA-based nanoparticles using a Biozen 3 µm dSEC-2 HPLC Column.
Document Type:
Technical Notes
Target Industries:
Techniques:
Brands:
Separation Modes:
Size Exclusion
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
